IL18BP and macrophage activation syndrome: Furthermore, inhibition of IFNγ in CpG-induced MAS results in reduction of MAS severity in IL-18BP-knockout mice (Girard-Guyonvarc'h et al., 2018), indicating that IFNγ is an important player in disease pathogenesis.